The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 401–500 of 1,810
Large animal models in the study of gynecological diseases
Cui, M., Liu, Y., Men, X., Li, T., Liu, D., & Deng, Y. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1110551 · Cited by 22
“, 1996) as well as cardiovascular disease (Shostrom et al., 2017; Plows et al., 2018).”
BackgroundLi, L., Wang, X., Zhao, W., & Chen, Y. (2022) · Genetics Research · doi:10.1155/2022/1500768 · Cited by 16
Piotrowska, K., Zgutka, K., Tkacz, M., & Tarnowski, M. (2023) · Antioxidants · doi:10.3390/antiox12081488 · Cited by 20
“Multiple hypotheses link aberrant hormone production in the placenta to maternal metabolic dysfunction and diminished insulin functionality [20,32] or GDM”
BackgroundA Glimpse at the Size of the Fetal Liver—Is It Connected with the Evolution of Gestational Diabetes?
Cozma, M.-A., Găman, M., Dobrică, E.-C., Boroghină, S. C., Iancu, M. A., Creţoiu, S. M., & SIMIONESCU, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157866 · Cited by 17
“The cutoff values for the OGTT are blood glucose of 92, 180, and 153 mg/dL, before administration of 75 g of oral glucose and one and two hours after, respectively [2,4,5,37].”
BackgroundMethodInfluentialGhaderian, M., Hemmat, M. B., Behdad, S., Saeedi, M., & Shahsanaei, F. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100658 · Cited by 16
Xu, J., Chen, Y., Zhao, J., Wang, J., Chen, J., Pan, X., Zhang, W., Zheng, J., Zou, Z., Chen, X., et al. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06594-w · Cited by 23
“Gestational diabetes mellitus is a metabolic disorder occurring during pregnancy [1], primarily resulting from insulin resistance and the progressive dysfunction of pancreatic β-cell [2].”
BackgroundAyoade, O. B., Shahrestani, S. A., & Ruan, C. (2025) · Electronics · doi:10.3390/electronics14132583 · Cited by 27
Légaré, C., Desgagné, V., Poirier, C., Thibeault, K., White, F., Clément, A., Scott, M. S., Jacques, P., Perron, P., Guérin, R., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002703 · Cited by 20
Ramanjaneya, M., Butler, A. E., Bashir, M., Bettahi, I., Moin, A. S. M., Ahmed, L., Elrayess, M. A., Hunt, S. C., Atkin, S. L., & Abou‐Samra, A. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001925 · Cited by 16
Yin, B., Ding, L., Chen, Z., Chen, Y., Zhu, B., & Zhu, Y. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110673 · Cited by 17
Genetics and Epigenetics: Implications for the Life Course of Gestational Diabetes
Lowe, W. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076047 · Cited by 21
“To compensate for the increase in insulin resistance, insulin secretion is enhanced due to an expansion of beta cell mass [1,4].”
BackgroundInfluentialJankowska, A., Grzesiak, M., Krekora, M., Dominowska, J., Jerzyńska, J., Kałużny, P., Wesołowska, E., Szadkowska‐Stańczyk, I., Trafalska, E., Kaleta, D., et al. (2021) · Nutrients · doi:10.3390/nu13030949 · Cited by 15
Wang, Z., Yuan, M., Xu, C., Zhang, Y., Ying, C., & Xiao, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.630287 · Cited by 17
“However, early identification of GDM is very difficult (2, 11), as GDM is a complex metabolic process of insulin resistance and islet b cell proliferation disorders (2, 12), with many changes in metabolic factors preceding hyperglycemia (13, 14).”
BackgroundConstruction of the experimental rat model of gestational diabetes
Chen, F., Ge, L., Jiang, X.-Y., Lai, Y.-T., Huang, P., Hua, J., Lin, Y., Lin, Y., & Jiang, X. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273703 · Cited by 22
Horvatiček, M., Perić, M., Bečeheli, I., Klasić, M., Žutić, M., Kesić, M., Desoyé, G., Radoš, S. N., Ivanišević, M., Hranilović, D., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10020467 · Cited by 16
“Excessive body fat before pregnancy is associated with an increased risk of gestational diabetes mellitus (GDM), a condition characterized by impaired glucose tolerance first recognized during pregnancy [3].”
BackgroundWalentowicz‐Sadlecka, M., Domaracki, P., Sadłecki, P., Siódmiak, J., Grabiec, M., Walentowicz, P., Moliz, M. T. A., & Odrowąż‐Sypniewska, G. (2019) · Disease Markers · doi:10.1155/2019/5870239 · Cited by 15
Association Between Neighborhood Deprivation in Early Pregnancy and Gestational Diabetes Mellitus
Liu, E. F., Ferrara, A. M., Sridhar, S. B., Greenberg, M., & Hedderson, M. M. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005521 · Cited by 16
“16 We selected this period because it is concurrent to the hormonal and health behaviors that are related to increased insulin resistance during pregnancy 17 and directly precedes GDM diagnosis.”
The role of ncRNA regulatory mechanisms in diseases—case on gestational diabetes
Gao, D., Ren, L., Hao, Y.-D., Schaduangrat, N., Liu, X., Yuan, S.-S., Yang, Y. R., Wang, Y., Shoombuatong, W., & Ding, H. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad489 · Cited by 17
“The development of GDM involves various mechanisms, including β -cell dysfunction, insulin resistance (IR), adipose tissue dysfunction, gluconeogenesis and oxidative stress [41].”
BackgroundFrança, D. C. H., França, E. L., Sobrevía, L., Barbosa, A. M. P., Honório‐França, A. C., & Rudge, M. V. C. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166737 · Cited by 19
Han, Z., Zhang, Y., Li, X., Chiu, W., Yin, Y., & Hou, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.689888 · Cited by 18
“Although clinical manifestations of GDM usually occur in the second or third trimester, evidence of abnormal placental development from as early as the first trimester has been reported, and dysregulation of various hormones and cytokines caused by GDMduring early pregnancy has been reported to lead to placental dysfu…”
BackgroundChatzakis, C., Sotiriadis, A., Demertzidou, E., Eleftheriades, A., Dinas, K. D., Vlahos, N., & Eleftheriades, M. I. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110222 · Cited by 15
Jin, H., Gao, Y. H., Chen, R., Zhang, Y., Qu, J., Bai, X., & Zhao, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14302 · Cited by 15
“Gestational diabetes mellitus (GDM) is defined as an impairment in glucose tolerance that occurs or is first detected during gestation and may not disappear after delivery [16].”
BackgroundPlacental Vimentin Expression in Preeclampsia and Gestational Diabetes Mellitus
Aşir, F., Oğlak, S. C., Korak, T., Taş, F., Yılmaz, M., Erdemci, F., Şahin, F., Ayaz, H., Yılmaz, E. Z., & Bolluk, G. (2024) · Gynecology Obstetrics and Reproductive Medicine · doi:10.21613/gorm.2023.1469 · Cited by 21
Exploring the Potential of Epigallocatechin Gallate in Combating Insulin Resistance and Diabetes
Yurtseven, K., & Yücecan, S. (2024) · Nutrients · doi:10.3390/nu16244360 · Cited by 16
Association between thyroid autoimmunity and gestational diabetes mellitus in euthyroid women
Sitoris, G., & Poppe, K. G. (2022) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 14
Fan, X., Wang, L., Jiao, R., Song, W., Liu, Y., & Yu, T. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14285 · Cited by 18
“As any degree of glucose intolerance with onset or first recognition during pregnancy [1], GDM has attracted worldwide attention as a pregnancy-associated disease resulting in not only maternal adverse outcomes, such as cesarean section [2], preeclampsia [3], hydramnios[4], premature rupture of membranes [5] and postp…”
BackgroundManuello, J., Verdejo‐Román, J., Torres-Espínola, F. J., Escudero-Marín, M., Catena, A., Cauda, F., & Campoy, C. (2022) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2022.05.005 · Cited by 16
Adipocytokines are not associated with gestational diabetes mellitus but with pregnancy status
Ebert, T., Gebhardt, C., Scholz, M. R., Schleinitz, D., Blüher, M., Stümvoll, M., Kovacs, P. L., Faßhauer, M., & Tönjes, A. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155088 · Cited by 15
Hashemipour, S., Zohal, M., Modarresnia, L., Kolaji, S., Panahi, H., Badri, M., Chopani, S. M., Kelishomi, S. E., Ghasemi, A., & Ghafelehbashi, H. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-06113-3 · Cited by 22
“From the pathogenesis point of view, insulin resistance and chronic inflammation are the most studied factors in the pathogenesis of GDM [4].”
BackgroundHuang, F., Zhang, S., Tian, Y., Li, L., Li, Y., Chen, X., Sun, X., Fan, Y., Ma, W., Liu, C., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108775 · Cited by 13
Parental obesity-induced changes in developmental programming
Cechinel, L. R., Batabyal, R., Freishtat, R. J., & Zohn, I. E. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.918080 · Cited by 15
“In a vicious cycle, placental dysfunction in obesity and gestational diabetes paradoxically leads to increased expression of placental glucose transporters, further increasing glucose uptake (Salomon et al., 2016; Plows et al., 2018).”
BackgroundProlactin effects on the pathogenesis of diabetes mellitus
Scairati, R., Auriemma, R. S., Vecchio, G. D., Meglio, S. D., Pivonello, R., & Colao, A. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14190 · Cited by 16
The Immunomodulatory Role of Regulatory T Cells in Preterm Birth and Associated Pregnancy Outcomes
Mureanu, N., Bowman, A., Porter-Wright, I. A., Verma, P., Efthymiou, A., Nicolaides, K. H., Scottà, C., Lombardi, G., Tribe, R. M., & Shangaris, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211878 · Cited by 17
Circulating levels of fibroblast growth factor 21 in gestational diabetes mellitus: a meta-analysis
Jia, J., Wei, W., Fan, Y., Liu, R., Shen, Y., Zhang, R., Yuan, G., & Zhou, H. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0481 · Cited by 17
“Women with GDM have an increased risk of obesity, type 2 diabetes mellitus (T2DM), and cardiovascular disease (CVD), along with their children [1-3].”
BackgroundInfluentialRees, A., Richards, O., Chambers, M., Jenkins, B. J., Cronin, J., & Thornton, C. A. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac003 · Cited by 23
“While not extensively studied there are changes in maternal systemic immunity with GDM including upregulation of the Th1 phenotype which alters the Th1/Th2 ratio in comparison to a normal pregnancy [147].”
BackgroundInfluentialJorquera, G., Fornes, R., Cruz, G., & Thomas‐Valdés, S. (2022) · Antioxidants · doi:10.3390/antiox11112294 · Cited by 18
“Gestational diabetes mellitus and pre-eclampsia are associated with increased risks of maternal and fetal adverse outcomes [2,32-34].”
BackgroundLü, D., Yang, M., Yao, Y., et al. (2019) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2019.09.015 · Cited by 15
CTRP-1 levels are related to insulin resistance in pregnancy and gestational diabetes mellitus
Deischinger, C., Leitner, K., Baumgartner-Parzer, S. M., Bancher‐Todesca, D., Kautzky‐Willer, A., & Harreiter, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-74413-1 · Cited by 14
Lu, Y., Liu, S.-L., Zhang, Y., Liang, F., Zhu, X., Xiao, Y., Wang, J., Ding, C., Banerjee, S., Yin, J., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1084896 · Cited by 17
“GDM shares many features with T2DM in pathogenesis, for instance, glucose metabolism and insulin resistance (17, 18).”
BackgroundNasab, S. J., Ghanavati, M., Clark, C. C. T., & Nasirian, M. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00313-2 · Cited by 19
“Overweight and obesity, maternal age, family history, or any form of diabetes and insulin resistance are the most common risk factors for GDM [25]; among them, obesity and insulin resistance have inversely related with Mediterranean diet.”
BackgroundMelero, V., Arnoriaga, M., Barabash, A., Valerio, J., del Valle, L., Martin O’Connor, R., de Miguel, M. P., Diaz, J. A., Familiar, C., Moraga, I., et al. (2023) · Nutrients · doi:10.3390/nu15143252 · Cited by 14
Association between thyroid autoimmunity and gestational diabetes mellitus in euthyroid women
Sitoris, G., Veltri, F., Ichiche, M., Kleynen, P., Praet, J.-P., Rozenberg, S., & Poppe, K. G. (2022) · European Thyroid Journal · doi:10.1530/etj-21-0142 · Cited by 24
Yang, X., Hu, R., Yao, L., Zhang, W., Shi, M., Gong, J., Yuan, X., Li, Y., Yan, J., Wang, Y., et al. (2024) · Food & Function · doi:10.1039/d4fo00671b · Cited by 14
Xiang, A. H., Lin, J. C., Chow, T., Martinez, M. P., Negriff, S. L., Page, K. A., McConnell, R., & Carter, S. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15308 · Cited by 16
Xiu, X., Lin, Y., Chen, Z., Lin, L., Zu, Y., & Yan, J. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1406492 · Cited by 17
Effects of dietary polyphenols on maternal and fetal outcomes in maternal diabetes
Zhao, L., Chang, Q., Cong, Z., Zhang, Y., Liu, Z., & Zhao, Y. (2023) · Food & Function · doi:10.1039/d3fo02048g · Cited by 15
Sgayer, I., Odeh, M., Wolf, M. F., Kaiyal, R. S., Aiob, A., Lowenstein, L., & Gratacós, E. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15254 · Cited by 14
Gestational diabetes among women of migrant origin in Finland—a population-based study
Bastola, K., Koponen, P., Skogberg, N., Gissler, M., & Kinnunen, T. I. (2021) · European Journal of Public Health · doi:10.1093/eurpub/ckab078 · Cited by 19
The application of procyanidins in diabetes and its complications: a review of preclinical studies
Zhang, Y., Li, M., Liu, H., Fan, Y., & Liu, H. H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1532246 · Cited by 30
“Insulin resistance gradually intensi fi es during pregnancy, ultimately leading to hyperglycemia (Jasmine et al., 2018; Kimber-Trojnar et al., 2018).”
Meal Timing and Glycemic Control during Pregnancy—Is There a Link?
Zhu, S., Surampudi, P. N., Field, N. T., & Chondronikola, M. (2021) · Nutrients · doi:10.3390/nu13103379 · Cited by 15
“Insufficient insulin secretion due to β-cell dysfunction and increased insulin resistance leads to hyperglycemia during pregnancy and GDM [31].”
BackgroundYang, J., Cao, Y., Qian, F., Grewal, J., Sacks, D. B., Chen, Z., Tsai, M. Y., Chen, J., & Zhang, C. (2025) · BMC Medicine · doi:10.1186/s12916-025-04258-w · Cited by 17
“These mechanisms include glucose homeostasis and insulin signaling and sensitivity (HbA1c, glucose, thyroid markers, IGF family markers, adipokines, glycine, and aspartic acid), inflammatory pathways (adipokines), and lipid (triglycerides, phospholipid FAs) and amino acid metabolism [49].”
Qin, Y., Bily, D., Aguirre, M., Zhang, K., & Xie, L. (2023) · Nutrients · doi:10.3390/nu15112459 · Cited by 19
Association Between Plasma Asprosin Levels and Gestational Diabetes Mellitus
Boz, İ. B., Aytürk, S., Salt, Ö., Sayın, N. C., & Dıbırdık, İ. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s424651 · Cited by 16
“GDM is detected in approximately 7% of all pregnancies (range, 1–14%) and leads to a number of risks for the mother and fetus during and after pregnancy.(9) The pathogenesis of GDM is thought to involve abnormal changes in the insulin signaling pathways of the adipose tissue and skeletal muscle system that occur durin…”
BackgroundMethodZhang, T., Ji, C., & Shi, R. (2019) · Europe PMC (PubMed Central) · Cited by 19
Cognitive Dysfunction of Pregnant Women with Gestational Diabetes Mellitus in Perinatal Period
Sana, S.-R.-G.-L., Deng, X., Guo, L., Wang, X., & Li, E. (2021) · Journal of Healthcare Engineering · doi:10.1155/2021/2302379 · Cited by 15
Silencing of ANGPTL8 Alleviates Insulin Resistance in Trophoblast Cells
Bai, Y., Du, Q., Zhang, L., Li, L., Wang, N., Wu, B., Li, P., & Li, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.635321 · Cited by 16
“Moreover, the maternal insulin sensitivity returns to pre-pregnancy levels within a few days of delivery (20).”
BackgroundLiu, Y., Geng, H. Z., Duan, B., Yang, X., Ma, A., & Ding, X. (2021) · BioMed Research International · doi:10.1155/2021/1984690 · Cited by 18
“dysfunction in a setting of chronic insulin resistance during pregnancy, and β-cell impairment and tissue insulin resistance represent critical components of the pathophysiology of GDM [58].”
BackgroundLi, P., Lin, S., Cui, J., Chen, X., Meng, Z., & Fan, J. (2022) · Journal of Women s Health · doi:10.1089/jwh.2020.8825 · Cited by 16
Leca, B. M., Kite, C., Lagojda, L., Davasgaium, A., Dallaway, A., Chatha, K. K., Randeva, H. S., & Kyrou, I. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1348970 · Cited by 13
Calcifediol (25OHD) Deficiency and Its Treatment in Women’s Health and Fertility
Arnanz, A., García-Velasco, J. A., & Neyro, J. L. (2022) · Nutrients · doi:10.3390/nu14091820 · Cited by 17
“Knowing that both the insufficiency and deficit of maternal 25(OH)D directly influence the results obtained from pregnancy, the possible influence of 25(OH)D on the development of GD has been evaluated in the scientific literature [76].”
BackgroundBulut, A., Akca, G., Aktan, A. K., AKBULUT, K. G., & Babül, A. (2021) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2021.05.019 · Cited by 14
Dong, Y., Hu, A., Han, B., Cao, M.-T., Liu, H., Li, Z.-G., Li, Q., & Zheng, Y.-J. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02429-2 · Cited by 17
He, H., Liu, Y., & Sun, M. (2021) · Bioengineered · doi:10.1080/21655979.2021.2001205 · Cited by 16
“It has been generally recognized that the etiology and pathogenesis of GDM is complicated, and multiple factors, such as genetics, environment, insulin resistance and dysfunctions of islet β-cells and placental lactogen production, may jointly contribute to its development [4].”
BackgroundSkarstad, H. M. S., Haganes, K. L., Sujan, M. A. J., Gellein, T. M., Johansen, M. K., Salvesen, K. Å., Hawley, J. A., & Moholdt, T. T. (2024) · Scientific Reports · doi:10.1038/s41598-024-72913-y · Cited by 15
“GDM is the development of glucose intolerance with onset or first recognition during pregnancy, brought on by an underlying chronic insulin resistance due to beta-cell dysfunction 2,3 .”
BackgroundYang, J., Zhang, C., Chavarro, J. E., Rich-Edwards, J. W., Wang, M., Fawzi, W. W., Manson, J. E., Lee, I.-M. M., Hu, F. B., & Tobias, D. K. (2021) · Diabetes Care · doi:10.2337/dc21-1692 · Cited by 17
Chen, Y., Qiu, C., Chen, J., Lü, L., Xu, J., & Sheng, Z. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00738-0 · Cited by 19
Tkachuk, A., Vasukova, E. A., Anopova, A. D., Каронова, Т. Л., Pustozerov, E., Teplova, Y. A., Eriskovskaya, A. I., Isakov, A. O., Vasilieva, E. Y., Kokina, M. A., et al. (2022) · Nutrients · doi:10.3390/nu14102157 · Cited by 14
“Although many risk factors for GDM are well known, including advanced maternal age, obesity, family history of diabetes, and ethnicity [4,5], the mechanism underlying the role of these factors in GDM predisposition remains an area of active research [6].”
BackgroundInositol Supplementation in the Prevention of Gestational Diabetes Mellitus
Tahir, F., & Majid, Z. (2019) · Cureus · doi:10.7759/cureus.5671 · Cited by 16
Delgado, A., & Louis, J. M. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.02.004 · Cited by 17
The Mystery of Exosomes in Gestational Diabetes Mellitus
Chen, T., & Liu, D. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2169259 · Cited by 15
“The pathogenesis of GDM is complex and has not been fully clar-i fi ed, which is believed to be related to insulin resistance, in fl ammation, oxidative stress, adipose tissue, and endothelial cell dysfunction [1, 2].”
Coetzee, A., Sadhai, N., Mason, D., Hall, D. R., & Conradie, M. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108421 · Cited by 14
“[21] Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH.”
BackgroundLiu, J., Li, J., Yang, K., Leng, J., Li, W., Yang, W., Huo, X., Yu, Z., Ronald, C. W., Hu, G., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108606 · Cited by 13
Oğlak, S. C., Yılmaz, E. Z., & Budak, M. Ş. (2024) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2024.2329880 · Cited by 15
Shen, H., Sun, J., Liu, J., Wang, L., & Dong, L. (2021) · Ginekologia Polska · doi:10.5603/gp.a2021.0077 · Cited by 20
“Hy-perglycemia that develops during pregnancy is one of the symptoms of gestational diabetes mellitus (GDM) [3, 4].”
BackgroundLu, T., Cárdenas, A., Perron, P., Hivert, M., Bouchard, L., & Greenwood, C. M. T. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01114-5 · Cited by 19
Yang, W., Braun, J. M., Vuong, A. M., Percy, Z., Xu, Y. Y., Xie, C., Deka, R., Calafat, A. M., Ospina, M., Yolton, K. A., et al. (2022) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2022.114026 · Cited by 14
Montero, C. G., Fraile‐Μartinez, O., León-Oliva, D. D., Boaru, D. L., García-Puente, L. M., León-Luis, J. A. D., Bravo, C., Díaz, R., López-González, L., Álvarez‐Mon, M., et al. (2023) · Antioxidants · doi:10.3390/antiox12111918 · Cited by 20
A Clinical Study on Gestational Diabetes Mellitus and the Hearing of Newborns
Zhou, J.-H., Yu, K., Ding, H., Zhu, Z., Han, L.-H., & Zhang, T. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s290647 · Cited by 13
“More than 80% of pregnant patients with diabetes mellitus have GDM, and less than 20% of them have pregestational diabetes mellitus.(9,10) It is reported that the incidence of GDM is 1–14% in the world, and the incidence is 1–5% in China.”
BackgroundGujski, M., Szukiewicz, D., Chołuj, M., Sawicki, W., & Bojar, I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113530 · Cited by 14
“It can therefore be assumed that, unlike in PGMO, in EGWG, metabolic disorders with insulin resistance at the forefront are revealed almost exclusively during pregnancy [26].”
BackgroundCASTORINO, K. N., Durnwald, C. P., Ehrenberg, S., Ehrhardt, N. M., Isaacs, D., Levy, C. J., Valent, A. M., & Continuous Glucose Monitoring for Gestational Diabetes Management Working Group (2024) · Journal of Women s Health · doi:10.1089/jwh.2023.0864 · Cited by 15
Vitamin B6 and diabetes and its role in counteracting advanced glycation end products
Vernì, F. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.02.005 · Cited by 17
Fato, B. R., Beard, S., Binder, N. K., Pritchard, N., Kaitu’u‐Lino, T. J., de Alwis, N., & Hannan, N. J. (2023) · Biomedicines · doi:10.3390/biomedicines11102660 · Cited by 13
“Gestational diabetes mellitus (GDM) affects around 16.5% of pregnancies world-wide [1].”
BackgroundInfluentialDelgado, A., & Louis, J. M. (2023) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2023.06.011 · Cited by 13
Soldavini, C. M., Piuri, G., Rossi, G., Corsetto, P. A., Benzoni, L., Maggi, V., Privitera, G., Spadafranca, A., Rizzo, A. M., & Ferrazzi, E. M. (2022) · Nutrients · doi:10.3390/nu14122502 · Cited by 16
“Changes driven by the fetoplacental unit in the maternal organism led to metabolic stress over the insulin, glucose, and lipid homeostatic systems [9,10].”
BackgroundJahan-Mihan, A., Leftwich, J., Labyak, C. A., Snyder, J., Berg, K., & Nodarse, R. R. (2025) · Nutrients · doi:10.3390/nu17233731 · Cited by 16
“In obesity, this adaptation becomes pathological, promoting gestational diabetes, fetal hyperinsulinemia, and increased adiposity [36,42,55–57].”
Song, S., Luo, Q., Zhong, X., Huang, M., & Zhu, J. (2025) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-025-07973-0 · Cited by 18
“The body's inability to effectively utilize insulin leads to an insufficient insulin supply to meet the increased demands of pregnancy, which is associated with chronic IR present before pregnancy [22].”
NRF2 deficiency leads to inadequate beta cell adaptation during pregnancy and gestational diabetes
Haidery, F., Lambertini, L., Tse, I., Dodda, S., García-Ocaña, A., Scott, D. K., & Baumel-Alterzon, S. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103566 · Cited by 16
The Importance of the Microbiota in Shaping Women’s Health—The Current State of Knowledge
Krupa-Kotara, K. H., Helisz, P., Gwioździk, W., & Grajek, M. K. (2022) · Applied Microbiology · doi:10.3390/applmicrobiol3010002 · Cited by 17
Gestational diabetes and determinants of adherence to healthy behaviors
Hashmi, I. A. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04754-7 · Cited by 12
Exercise and the Prevention of Gestational Diabetes Mellitus
Woodside, A., & Bradford, H. M. (2021) · Nursing for Women s Health · doi:10.1016/j.nwh.2021.05.009 · Cited by 16
Zhang, Y., Jin, W., Zhang, D., Lin, C., He, H., Xie, F., Gan, L., Fu, W., Wu, L., & Wu, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9142798 · Cited by 20
Wang, Q., Zhang, K., Zhang, X., Fu, J., Liu, F., Gao, Y., & Lin, R. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111943 · Cited by 17
The Incidence and Management of Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus
Ikoh, C. L., & Tinong, R. T. (2023) · Cureus · doi:10.7759/cureus.44468 · Cited by 31
“Advanced maternal age, being overweight, and a family history of diabetes are some of the risk factors for GDM [2].”
BackgroundEllerbrock, J., Hubers, E., Ghossein‐Doha, C., Schiffer, V. M. M. M., Alers, R., Jorissen, L. M., van Neer, J., Zelis, M., Janssen, E. B. N. J., Landewé-Cleuren, S. A. N. T., et al. (2022) · Nutrients · doi:10.3390/nu14142933 · Cited by 12
“Consequently, fortified fetal glucose storage and the stimulated endogenous production of insulin-like growth factor (IGF-1), both contributing to overgrowth, raise and lower the prevalence of LGA and SGA, respectively [3].”
BackgroundIncretins as a Potential Treatment Option for Gestational Diabetes Mellitus
Pilszyk, A., Niebrzydowska-Tatus, M., Pilszyk, Z., Wierzchowska-Opoka, M., & Kimber-Trojnar, Ż. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710101 · Cited by 17
“It can completely resolve after delivery or persist as diabetes is revealed during pregnancy [1].”
BackgroundInfluentialLife-course management of gestational diabetes mellitus: A narrative review
Luo, Q.-J., & Ni, Q. (2025) · World Journal of Clinical Cases · doi:10.12998/wjcc.v13.i29.111096 · Cited by 16
The Role of Hexokinase Domain Containing Protein-1 in Glucose Regulation During Pregnancy
Zapater, J. L., Lednovich, K., & Layden, B. T. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01394-4 · Cited by 21
Jones, M., Ionescu, C. M., Walker, D., Wagle, S. R., Kovačević, B., Chester, J., Foster, T., Johnston, E., Kuthubutheen, J., Brown, D. J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020836 · Cited by 15
“Tissue resistance to insulin is an additional contributing factor to β-cell dysfunction, as there is a reduction in insulin-induced uptake of glucose [21,22].”
BackgroundMechanisms and Physiological Roles of Polymorphisms in Gestational Diabetes Mellitus
Suthon, S., & Tangjittipokin, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042039 · Cited by 14
Bao, Y., Zhang, J., Liu, Y., Wu, L., & Yang, H. J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1050906 · Cited by 16
“When maternal β-cells cannot adapt to the metabolic changes accompanying pregnancy, GDM develops as a result of these changes (Plows et al., 2018).”
Background
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.